Use of an LTB 4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes

Inventors: Christopher Meade, Franz Birke, Ralf Anderskewitz, Hans-Michael Jennewein, Birgit Jung

Provisional Application Expired

	Code	Description	Pages	PDF
2001-02-06	`TRNA`	Transmittal of New Application	2	View
2001-02-06	`SPEC`	Specification	11	View
2001-02-06	`CLM`	Claims	3	View
2001-02-06	`ABST`	Abstract	1	View

Inventors

Christopher Meade Bingen, GERMANY

Franz Birke Ingelheim, GERMANY

Ralf Anderskewitz Bingen, GERMANY

Hans-Michael Jennewein Wiesbaden, GERMANY

Birgit Jung Schwabenheim, GERMANY

Attorneys & Agents of Record

TIMOTHY WITKOWSKI Reg. 40232 Attorney · NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH

PHILIP DATLOW Reg. 41482 Attorney · BOEHRINGER INGELHEIM, CORPORATION

MARY SMITH Reg. 43512 Attorney · BOEHRINGER INGELHEIM USA CORPORATION

DAVID DOW Reg. 46124 Attorney · BOEHRINGER INGELHEIM PHARMACERTICALS, INC.

SHELLEY JONES Reg. 53081 Attorney · BOEHRINGER INGELHEIM USA CORP.

DAVID KERSHNER Reg. 53112 Attorney · BOEHRINGER INGELHEIM CORPORATION

PAULA WITTMAYER Reg. 53785 Attorney · BOEHRINGER INGELHEIM CORPORATION

WENDY GOMBERT Reg. 61968 Attorney · BOEHRINGER INGELHEIM VETMEDICA, INC.

KENNETH KALAFUS Reg. 66175 Attorney · BOEHRINGER INGELHEIM USA CORPORATION

Prosecution

No recorded assignments were found for this patent.

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Pre-filled with this application's details

Quick Facts

External Links